Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Serum samples from 20 participants who had received two doses of the BNT162b2 vaccine and from 20 who had received three doses were assessed for ability to neutralize the omicron variant of SARS-CoV-2 in vitro. Neutralization activity was poor after two vaccine doses. However, substantial neutralization of the omicron variant was detected in sample...
Alternative Titles
Full title
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8823651
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8823651
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2119358
